Identification and Characterisation of Sleep Disorders in a Population of Patients With Non-small Cell Lung Cancer

Launched by UNIVERSITY HOSPITAL, STRASBOURG, FRANCE · Jul 2, 2024

Keywords

ClinConnect Summary

This clinical trial is looking at how sleep disorders affect patients with non-small cell lung cancer. Many patients report that their sleep problems impact their overall quality of life. By identifying and understanding these sleep disorders, the researchers aim to create a helpful guide or “decision tree” that will make it easier for doctors to diagnose, refer, and treat sleep issues in cancer patients. This could lead to better management of sleep problems and improve the well-being of those undergoing cancer treatment.

To be eligible for this study, participants need to be at least 18 years old, currently receiving treatment for non-small cell lung cancer, and able to understand and complete questionnaires in French. It's important that they are in good enough health to participate, meaning they should expect to live for more than three months and have no severe health issues. Participants will be asked to fill out some questionnaires about their sleep and health, and they should be reachable by phone throughout the study. If you or someone you know is dealing with lung cancer and has sleep problems, this study may provide valuable insights and support.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patient aged 18 and over.
• • Being monitored and treated for non-small cell lung cancer.
• • With or without ongoing cancer-specific treatment. With no neurocognitive impairment (MoCA test score ≥26/30).
• • With a clinically assessed life expectancy of more than 3 months (Royal Marsden Hospital 0-1) and general health (ECOG \<2).
• • Able to understand the study documents written in French
• • Able to complete the study questionnaires written in French.
• • Contactable by telephone throughout the study
• • Affiliated to a social security scheme or entitled beneficiary
• • Not opposed to taking part in the study
• Exclusion Criteria:
• • Patient refusing to take part in the study
• • With a mental illness of the psychosis type monitored and treated prior to the study
• • Patient under guardianship or curatorship
• • Patient under court protection